Search Within

Lisa Bodei

  1. "2021"
Formats
  1. Review (11)
  2. Journal Article (7)
  3. Meeting Abstract (7)
  4. Conference Paper (1)
  5. Guidelines (1)
Groups
  1. Molecular Imaging and Therapy Service (27)
  2. Radiology, Department of (27)
  3. Sloan Kettering Institute Postdocs (27)
  4. Department of Medicine (5)
  5. Solid Tumor Oncology Division (4)
  6. Center for Molecular Imaging and Biotechnology (3)

More Groups

People
  1. Heiko Schoder (3)
  2. Diane Reidy (2)
  3. Michael Morris (2)
  4. Nagavarakishore Pillarsetty (2)
  5. Nitya Raj (2)
  6. Sang Gyu Lee (2)

More People

Years
  1. 2021 (27)
Publications
  1. Journal of Nuclear Medicine (5)
  2. European Journal of Nuclear Medicine and Molecular Imaging (4)
  3. Annals of Oncology (3)
  4. Current Opinion in Endocrine and Metabolic Research (2)
  5. Journal of Clinical Oncology (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (5)
  2. Springer (5)
  3. Elsevier Inc. (4)
  4. Oxford University Press (3)
  5. American Society of Clinical Oncology (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The phase 3 NETTER-1 study of [(177)Lu-]Lu-DOTA-TATE in patients with midgut neuroendocrine tumours: Final overall survival and long-term renal safety
    Meeting Abstract

    Kunz, P.; Caplin, M. E.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • (177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): Final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
    Journal Article

    Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors
    Meeting Abstract

    Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A. E.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
    Journal Article

    Modlin, I. M.; Kidd, M.; Falconi, M.; Filosso, P. L.; Frilling, A.; Malczewska, A.; Toumpanakis, C.; Valk, G.; Pacak, K.; Bodei, L.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Somatostatin receptor imaging and theranostics: Current practice and future prospects
    Review

    Park, S.; Parihar, A. S.; Bodei, L.; Hope, T. A.; Mallak, N.; Millo, C.; Prasad, K.; Wilson, D.; Zukotynski, K.; Mittra, E.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
    Meeting Abstract

    Ruszniewski, P. B.; Caplin, M. E.; Kunz, P. L.; Bodei, L.; Hendifar, A. E.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: Implications for patient management
    Review

    Roll, W.; Weckesser, M.; Seifert, R.; Bodei, L.; Rahbar, K.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Early identification of residual disease after neuroendocrine tumor resection using a liquid biopsy multigenomic mRNA signature (NETest)
    Journal Article

    Modlin, I. M.; Kidd, M.; Oberg, K.; Falconi, M.; Filosso, P. L.; Frilling, A.; Malczewska, A.; Salem, R.; Toumpanakis, C.; Laskaratos, F. M.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Synergism of checkpoint inhibitors and peptide receptor radionuclide therapy in the treatment of pituitary carcinoma
    Journal Article

    Lin, A. L.; Tabar, V.; Young, R. J.; Cohen, M.; Cuaron, J.; Yang, T. J.; Rosenblum, M.; Rudneva, V. A.; Geer, E. B.; Bodei, L.
    Journal of the Endocrine Society (2021)

    Fulltext@MSK | Save